Pyc Therapeutics Ltd (PYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2005 | |
| Cash Flows From Operating Activities | |
| Operating Cash Flow | $N/A |
| Cash Flows From Investing Activities | |
| PPE Investments | -41 |
| Purchase Sale Intangibles | -183 |
| Investing Cash Flow | $-225 |
| Cash Flows From Financing Activities | |
| Debt Issued | -552 |
| Common Stock Issued | 7,429 |
| Common Stock Repurchased | -606 |
| Financing Cash Flow | $6,270 |
| Beginning Cash Position | 791 |
| End Cash Position | 5,505 |
| Net Cash Flow | $4,714 |
| Free Cash Flow | |
| Capital Expenditure | -225 |
| Free Cash Flow | -225 |